Previous close | 9.50 |
Open | 9.50 |
Bid | 8.30 |
Ask | 12.00 |
Strike | 31.00 |
Expiry date | 2023-02-17 |
Day's range | 9.50 - 9.50 |
Contract range | N/A |
Volume | |
Open interest | N/A |
In this article we are going to estimate the intrinsic value of Corcept Therapeutics Incorporated ( NASDAQ:CORT ) by...
Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since approval. However, sole dependence on Korlym for revenues remains a headwind.
Durect (DRRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.